Meiji Yasuda Life Insurance CO Amgen Inc Transaction History

Meiji Yasuda Life Insurance CO

$4.99 Billion
Q1 2025

A detailed history of Meiji Yasuda Life Insurance CO transactions in Amgen Inc stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 21,770 shares of AMGN stock, worth $6.08 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

21,770

Previous 23,194 6.14%

Holding current value

$6.08 Million

Previous $6.05 Million 12.19%

% of portfolio

0.14%

Previous 0.11%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$258.59 - $327.36 $368,232 - $466,160	-1,424 Reduced 6.14%	21,770 $6.78 Million
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $992,938 - $1.26 Million	-3,837 Reduced 14.19%	23,194 $6.05 Million
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $277,513 - $302,629	897 Added 3.43%	27,031 $8.71 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $2.17 Million - $2.64 Million	8,271 Added 46.3%	26,134 $8.17 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $1.56 Million - $1.88 Million	5,786 Added 47.91%	17,863 $5.08 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $678,116 - $764,995	2,652 Added 28.14%	12,077 $3.48 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $417,621 - $518,488	1,910 Added 25.42%	9,425 $2.53 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $641,952 - $759,096	-2,996 Reduced 28.5%	7,515 $1.67 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $16,708 - $20,364	-74 Reduced 0.7%	10,511 $2.54 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $48,096 - $61,112	-210 Reduced 1.95%	10,585 $2.78 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $645,098 - $727,553	2,874 Added 36.28%	10,795 $2.43 Million
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $1.24 Million - $1.38 Million	5,364 Added 209.78%	7,921 $1.93 Million
Q1 2022 May 17, 2022	SELL	$219.27 - $242.57 $225,848 - $249,847	-1,030 Reduced 28.71%	2,557 $618,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $18,296 - $20,939	-92 Reduced 2.5%	3,587 $807,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $631,927 - $740,379	-2,977 Reduced 44.73%	3,679 $782,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $215,127 - $238,667	-921 Reduced 12.16%	6,656 $1.62 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $55,699 - $64,908	-251 Reduced 3.21%	7,577 $1.89 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $911,176 - $1.09 Million	-4,211 Reduced 34.98%	7,828 $1.8 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $64,998 - $72,283	277 Added 2.36%	12,039 $3.06 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $105,630 - $129,623	534 Added 4.76%	11,762 $2.77 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $315,639 - $418,624	-1,732 Reduced 13.36%	11,228 $2.28 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $146,448 - $188,236	-774 Reduced 5.64%	12,960 $3.12 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $444,851 - $533,024	2,555 Added 22.86%	13,734 $2.66 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $55,344 - $64,876	-332 Reduced 2.88%	11,179 $2.06 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $475,868 - $536,408	-2,631 Reduced 18.6%	11,511 $2.19 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $265,280 - $309,667	-1,487 Reduced 9.51%	14,142 $2.75 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $562,169 - $633,772	3,034 Added 24.09%	15,629 $3.24 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $249,241 - $279,951	1,501 Added 13.53%	12,595 $2.33 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $491,855 - $574,794	-2,903 Reduced 20.74%	11,094 $1.89 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $418,599 - $467,703	2,480 Added 21.53%	13,997 $2.43 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.93 Million - $2.2 Million	11,517	11,517 $2.15 Million

Others Institutions Holding AMGN

# of Institutions

3,306

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.

Account

Meiji Yasuda Life Insurance CO Amgen Inc Transaction History